3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Prostatic Neoplasms
3
Carcinoma, Non-Small-Cell Lung
3
Lung Neoplasms
2
Leukemia, Myeloid, Acute
2
Carcinoma, Renal Cell
2
Brain Neoplasms
2
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Triple Negative Breast Neoplasms
1
Squamous Cell Carcinoma of Head and Neck
1
Rectal Neoplasms
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Oropharyngeal Neoplasms
1
Non-Muscle Invasive Bladder Neoplasms
1
Neoplasms
1
Melanoma
1
Lymphoma, Mantle-Cell
1
Head and Neck Neoplasms
1
Carcinoma, Squamous Cell
1
Breast Neoplasms
1
Breast Carcinoma In Situ
1
Anus Neoplasms
1
Anatomic Stage II Breast Cancer AJCC v8
1
Anal Canal Carcinoma
1
Interventions
Specimen Handling
6
Magnetic Resonance Spectroscopy
6
Nivolumab
4
Cisplatin
4
Platinum
3
Gemcitabine
3
1,2-diaminocyclohexaneplatinum II citrate
3
Ipilimumab
2
Immunoglobulin G
2
Immune Checkpoint Inhibitors
2
Disulfides
2
Carboplatin
2
Capecitabine
2
CTLA-4 Antigen
2
Biopsy
2
toripalimab
1
tislelizumab
1
relatlimab
1
pembrolizumab
1
olaparib
1
fluciclovine F-18
1
cemiplimab
1
cabozantinib
1
atezolizumab
1
X-Rays
1
Transurethral Resection of Bladder
1
Radiotherapy, Intensity-Modulated
1
Radiotherapy
1
Radiation
1
Phantoms, Imaging
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Nasopharyngeal Carcinoma
×
Watchful Waiting
×
30 days
×
Clear all
No trials found.